PepGen Inc. (PEPG)
3.18
-0.03
(-0.93%)
USD |
NASDAQ |
Sep 09, 14:48
PepGen Price : 3.18 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 3.06 | 3.240 | 2.91 | 3.21 | 1.930M |
| Sep 04, 2026 | 3.14 | 3.195 | 3.10 | 3.11 | 201001.0 |
| Sep 03, 2026 | 3.18 | 3.25 | 3.10 | 3.18 | 514339.0 |
| Sep 02, 2026 | 3.15 | 3.30 | 3.085 | 3.18 | 354291.0 |
| Sep 01, 2026 | 2.95 | 3.165 | 2.91 | 3.12 | 461777.0 |
| Aug 31, 2026 | 3.04 | 3.05 | 2.92 | 2.99 | 365815.0 |
| Aug 28, 2026 | 3.05 | 3.13 | 2.98 | 3.08 | 484907.0 |
| Aug 27, 2026 | 3.22 | 3.30 | 3.07 | 3.07 | 474486.0 |
| Aug 26, 2026 | 3.41 | 3.41 | 3.11 | 3.22 | 952367.0 |
| Aug 25, 2026 | 3.21 | 3.57 | 3.19 | 3.425 | 984987.0 |
| Aug 24, 2026 | 3.14 | 3.23 | 3.04 | 3.19 | 482826.0 |
| Aug 21, 2026 | 3.09 | 3.23 | 3.031 | 3.14 | 672160.0 |
| Aug 20, 2026 | 3.04 | 3.18 | 3.03 | 3.035 | 969827.0 |
| Aug 19, 2026 | 2.98 | 3.08 | 2.875 | 3.05 | 780072.0 |
| Aug 18, 2026 | 3.03 | 3.085 | 2.895 | 2.91 | 677248.0 |
| Aug 17, 2026 | 3.00 | 3.08 | 2.93 | 3.04 | 670959.0 |
| Aug 14, 2026 | 2.95 | 3.00 | 2.85 | 2.99 | 615462.0 |
| Aug 13, 2026 | 2.90 | 3.05 | 2.80 | 2.98 | 1.395M |
| Aug 12, 2026 | 2.86 | 2.98 | 2.86 | 2.90 | 768009.0 |
| Aug 11, 2026 | 3.04 | 3.14 | 2.86 | 2.90 | 1.145M |
| Aug 10, 2026 | 2.90 | 3.04 | 2.75 | 2.99 | 1.525M |
| Aug 07, 2026 | 2.48 | 2.875 | 2.44 | 2.85 | 3.224M |
| Aug 06, 2026 | 2.10 | 2.46 | 2.06 | 2.41 | 4.476M |
| Aug 05, 2026 | 1.96 | 1.99 | 1.87 | 1.98 | 668204.0 |
| Aug 04, 2026 | 1.88 | 1.95 | 1.84 | 1.93 | 357206.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 83.36 |
| Oncolytics Biotech, Inc. | 0.8033 |
| Sangamo Therapeutics, Inc. | 0.1609 |
| Sarepta Therapeutics, Inc. | 22.22 |
| Anixa Biosciences, Inc. | 2.845 |
Price Related Metrics
| Price to Book Value | 1.843 |
| Earnings Yield | -41.06% |
| Market Cap | 220.25M |